A detailed history of Neuberger Berman Group LLC transactions in Cerus Corp stock. As of the latest transaction made, Neuberger Berman Group LLC holds 15,298 shares of CERS stock, worth $27,383. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,298
Previous 18,017 15.09%
Holding current value
$27,383
Previous $31,000 16.13%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.7 - $2.39 $4,622 - $6,498
-2,719 Reduced 15.09%
15,298 $26,000
Q2 2024

Nov 14, 2024

BUY
$1.62 - $2.04 $9,486 - $11,946
5,856 Added 48.15%
18,017 $31,000
Q2 2024

Aug 13, 2024

BUY
$1.62 - $2.04 $29,187 - $36,754
18,017 New
18,017 $31,000
Q4 2023

Nov 14, 2024

SELL
$1.25 - $2.35 $7,320 - $13,761
-5,856 Reduced 32.5%
12,161 $26,000
Q4 2023

Feb 09, 2024

BUY
$1.25 - $2.35 $15,201 - $28,578
12,161 New
12,161 $26,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.